Humana Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Humana is forecast to grow earnings and revenue by 44.1% and 4% per annum respectively while EPS is expected to grow by 42.4% per annum.

Anahtar bilgiler

44.1%

Kazanç büyüme oranı

42.4%

EPS büyüme oranı

Healthcare kazanç büyümesi34.2%
Gelir büyüme oranı4.0%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme24 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Oct 31
Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Oct 27
kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Jul 22
Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09
Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12
Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Does Humana (STO:HUM) Have A Healthy Balance Sheet?

Mar 18
Does Humana (STO:HUM) Have A Healthy Balance Sheet?

At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Feb 01
At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Is Humana (STO:HUM) Using Too Much Debt?

Oct 21
Is Humana (STO:HUM) Using Too Much Debt?

Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Mar 31
Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Is Humana (STO:HUM) Using Too Much Debt?

Nov 22
Is Humana (STO:HUM) Using Too Much Debt?

Shareholders Can Be Confident That Humana's (STO:HUM) Earnings Are High Quality

Aug 28
Shareholders Can Be Confident That Humana's (STO:HUM) Earnings Are High Quality

Kazanç ve Gelir Büyüme Tahminleri

OM:HUM - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202611,0063664764761
12/31/202510,5132364394062
12/31/202410,2271713013041
9/30/202410,014124739909N/A
6/30/20249,746110445615N/A
3/31/20249,621146484654N/A
12/31/20239,649176451621N/A
9/30/20239,685228316508N/A
6/30/20239,660250414606N/A
3/31/20239,491232414606N/A
12/31/20229,203210441633N/A
9/30/20228,869183490520N/A
6/30/20228,530203465582N/A
3/31/20228,347242481598N/A
12/31/20218,186276572689N/A
9/30/20218,000293593813N/A
6/30/20217,896279670803N/A
3/31/20217,825272603736N/A
12/31/20207,771262528661N/A
9/30/20207,750230543613N/A
6/30/20207,739249595703N/A
3/31/20207,670197434662N/A
12/31/20197,446188403631N/A
9/30/20197,247222327556N/A
6/30/20197,005196173416N/A
3/31/20196,774245265425N/A
12/31/20186,714246158332N/A
9/30/20186,600228252396N/A
6/30/20186,550197N/A346N/A
3/31/20186,541199N/A216N/A
12/31/20176,542194N/A241N/A
9/30/20176,635195N/A-185N/A
6/30/20176,684241N/A-153N/A
3/31/20176,540226N/A-143N/A
12/31/20166,362148N/A-161N/A
9/30/20166,140139N/A255N/A
6/30/20165,868-11N/A202N/A
3/31/20165,713-53N/A233N/A
12/31/20155,59328N/A274N/A
12/31/20145,06538N/A156N/A
12/31/20133,489111N/A196N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: HUM's forecast earnings growth (44.1% per year) is above the savings rate (1.1%).

Kazançlar ve Piyasa: HUM's earnings (44.1% per year) are forecast to grow faster than the Swedish market (15.7% per year).

Yüksek Büyüme Kazançları: HUM's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: HUM's revenue (4% per year) is forecast to grow faster than the Swedish market (0.02% per year).

Yüksek Büyüme Geliri: HUM's revenue (4% per year) is forecast to grow slower than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if HUM's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin